Skip to main content
logo
BioNxt Solutions Inc. (CSE:BNXT)
Canada flag Canada · Delayed Price · Currency is CAD
0.3250
+0.0250 (8.33%)
Aug 10, 2026, 11:47 AM EST

BioNxt Solutions Financials Overview

Millions CAD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.030.370.30.29
Revenue Growth
---92.75%25.15%3.82%-17.11%
Gross Profit
--0.030.37-0.410.2
Operating Income
-6.88-5.93-4.45-6.36-6.57-16.21
Net Income
-9.3-7.03-5.31-7.72-12.38-20.64
Earnings Per Share
-0.08-0.06-0.05-0.08-0.15-0.29
EPS Growth
------

Revenue by Geography
Chart
Fiscal YearFY 2024FY 2023FY 2022FY 2021
Period EndingDec '24 Dec '23 Dec '22 Dec '21
Germany
0.020.020.020.13
Austria
0.010.080.270.11
Switzerland
0000
Total
0.030.370.30.29

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.010.060.030.360.141.35
Total Debt
6.35.954.284.894.375.46
Net Cash (Debt)
-6.29-5.89-4.25-4.53-4.23-4.1
Net Cash Growth
------
Net Cash Per Share
-0.05-0.05-0.04-0.05-0.05-0.06

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.47-5.2-3.03-5.17-6.23-12.16
Capital Expenditures
----0.2-0-0.45
Free Cash Flow
-4.47-5.2-3.03-5.37-6.23-12.61
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%100.00%-138.28%69.63%
Operating Margin
---16502.86%-1708.42%-2210.02%-5659.36%
Pretax Margin
---20015.92%-2074.68%-4326.89%-7241.88%
Profit Margin
---19683.18%-2074.68%-4160.84%-7203.23%
FCF Margin
---11243.72%-1442.32%-2095.73%-4400.52%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--1596.92139.87180.92292.73